Endurant Capital Management LP
- SEC CIK
- 0001633055
- Latest filing
- May 7, 2024
The latest 13F from Endurant Capital Management LP covers Q1 2024 (filed May 7, 2024) and reports no long positions. Livermore has 14 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q1 2024
Share counts compared with Q4 2023: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 0
- Added
- 0
- Reduced
- 0
- Sold out
- 25
- Est. −$17.4M
Top 5 holdings
Share of this quarter's portfolio value
This filing reports no long positions.
Biggest buys
New and added positions, by estimated amount bought
None this quarter.
Largest weight increases
New and added positions, by percentage points of the portfolio gained
None this quarter.
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q1 2024, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $0
- −$17.4M (−100.0%) vs. prior quarter
- Positions
- 0
- −25 vs. prior quarter
- Top 10 concentration
- –
- Top 10 as share of value
- Turnover
- 0.0%
- Q1 2024, one quarter
- Average holding period
- –
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
13 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $369.8M (Q4 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q1 2024 | May 7, 2024 | 0 | $0 | – | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 25 | $17.4M | BSXTMOAXNX | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 43 | $111.3M | BMRNTMOBRKR | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 30 | $77.6M | LHCIMRK | vs. Q1 2023 | SEC |
| Q1 2023 | May 15, 2023 | 49 | $194.7M | BMRNBDXELV | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 14, 2023 | 55 | $246.3M | Invacare CorpLHCI | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 49 | $307.0M | Invacare CorpLHHUM | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 15, 2022 | 47 | $262.2M | Invacare CorpQGENBSX | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 60 | $331.3M | Invacare CorpCNCLH | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 14, 2022 | 65 | $369.8M | Invacare CorpSNYLH | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 51 | $329.0M | Invacare CorpABBVHUM | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 27, 2021Amended | 57 | $363.8M | Invacare CorpLHCI | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 60 | $368.3M | KIDSInvacare CorpBMY | – | SEC |
13D and 13G filings
Companies where Endurant Capital Management LP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
Endurant Capital Management LP does not currently report owning 5% or more of any company.
Latest filings
11 filings on file made by Endurant Capital Management LP or listing it as a reporting person, newest first.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| IVCInvacare Holdings Corp | Oct 30, 2024 | 13D/AOld format | – | – | – | SEC |
| IVCInvacare Holdings Corp | Apr 10, 2024 | 13D/AOld format | – | – | – | SEC |
| IVCInvacare Holdings Corp | Sep 8, 2023 | 13D/AOld format | – | – | – | SEC |
| IVCInvacare Holdings Corp | May 15, 2023 | 13DOld format | – | New | – | SEC |
| ELUTElutia Inc. | Mar 21, 2023 | 13G/AOld format | – | – | – | SEC |
| ELUTElutia Inc. | Feb 14, 2023 | 13G/AOld format | – | – | – | SEC |
| ELUTElutia Inc. | Feb 14, 2023 | 13G/AOld format | – | – | – | SEC |
| ELUTElutia Inc. | Feb 14, 2022 | 13G/AOld format | – | – | – | SEC |
| ELUTElutia Inc. | Jun 9, 2021 | 13GOld format | – | New | – | SEC |
| Oxford Immunotec Global PLC | Feb 17, 2021 | 13G/AOld format | – | – | – | SEC |
| Oxford Immunotec Global PLC | Feb 12, 2021 | 13GOld format | – | New | – | SEC |